Signals, Powered By EquityPandit
The US health regulator has provided its approval to Strides Shasun for Amantadine Hydrochloride tablets that are used in the treatment of Parkinson’s disease and Shingles to reduce pain.
Strides Shasun has said in a regulatory filing that “The product received approval in 15 months under the new GDUFA regime.”
It further said that “Strides Shasun…. has received approval from the USFDA for Amantadine Hydrochloride tablets 100 mg.”
